Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

about

Long-term Survivors of Childhood Brain Tumors: Impact on General Health and Quality of Life.HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma.

P2860

Q47621430-17D37A13-0859-4F5F-98B9-94A916EB1FA4 Q47851025-1CC707C3-CC71-426C-832A-A8880EFD4C63

P2860

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

Item

http://www.wikidata.org/entity/Q39225738

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

@en

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

@nl

type

Item

label

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

@en

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

@nl

prefLabel

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

@en

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

@nl

P1476

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

@en

P2093

Elizabeth L Mahoney

http://www.w3.org/2001/XMLSchema#string

Scott L Pomeroy

http://www.w3.org/2001/XMLSchema#string

Tenley C Archer

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Molecular subgroups of medulloblastoma: the current consensus

Dissecting the genomic complexity underlying medulloblastoma

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation

Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine

P2888

s13311-017-0526-y

P304

265-273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-017-0526-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28386677

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

P932

5398996

http://www.w3.org/2001/XMLSchema#string

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

about

P2860

P2860

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932